R&D-OTHER R & D-A RES/EXPL DEV
R&D-OTHER R & D-A RES/EXPL DEV
批准号:
8125388
负责人:
ETHAN M. BASCH
金额:
$86.22万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-30 至 2012-07-29
关键词:
Adverse eventAgeAwarenessCancer PatientClinicalClinical TrialsCommon Terminology Criteria for Adverse EventsComplementComprehensionConfidentialityContractorDataData CollectionData ReportingEducational MaterialsElectronicsElementsFrequenciesHealth PersonnelHealth StatusLanguageLengthMonitorNursesOutcome MeasurePaperPatient CarePatient Outcomes AssessmentsPatientsPhysiciansReportingSecuritySensitivity and SpecificitySeveritiesSex CharacteristicsSolutionsSurveysSymptomsSystemTrainingTranslationsValidity and Reliabilitybasehealth related quality of lifeimprovedinstrumentinteroperabilitymeetingsresponsesoftware systemstooluser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Contractor shall develop the Patient-Reported Outcomes version of symptom elements that are contained
within the Common Terminology Criteria for Adverse Events (PRO-CTCAE). This system will collect cancer patients'
responses to questions about their health status, symptoms, functioning and health-related quality of life and integrate
this information within the NCI adverse event reporting system.
The Contractor shall produce a detailed document that identifies barriers, ideal conditions, and solutions to implement
the PRO-CTCAE, develop the PRO-CTCAE assessment software system fully integrated with the CTCAE, conduct
studies to evaluate the validity, reliability, feasibility and clinical utility of the new PRO-CTCAE, and create Training
and Educational Materials to Support the PRO-CTCAE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
-
批准号:10884103
-
项目类别:
-
资助金额:$26.92万
-
财政年份:2023
-
负责人:ETHAN M. BASCH
-
依托单位:
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
-
批准号:9789216
-
项目类别:
-
资助金额:$53.77万
-
财政年份:2018
-
负责人:ETHAN M. BASCH
-
依托单位:
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
-
批准号:10005036
-
项目类别:
-
资助金额:$53.09万
-
财政年份:2018
-
负责人:ETHAN M. BASCH
-
依托单位:
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
-
批准号:10475645
-
项目类别:
-
资助金额:$55.43万
-
财政年份:2018
-
负责人:ETHAN M. BASCH
-
依托单位:
TAS::75 0849::TAS - PATIENT REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY
-
批准号:8165963
-
项目类别:
-
资助金额:$153.78万
-
财政年份:2010
-
负责人:ETHAN M. BASCH
-
依托单位:
TAS::75 0849::TAS - PATIENT REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY
-
批准号:8338732
-
项目类别:
-
资助金额:$176.98万
-
财政年份:2010
-
负责人:ETHAN M. BASCH
-
依托单位:
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting
-
批准号:7922782
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2009
-
负责人:ETHAN M. BASCH
-
依托单位:
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting
-
批准号:7778917
-
项目类别:
-
资助金额:$13.4万
-
财政年份:2008
-
负责人:ETHAN M. BASCH
-
依托单位:
Cancer Care Quality Research Training Program
-
批准号:8904622
-
项目类别:
-
资助金额:$42.98万
-
财政年份:2008
-
负责人:ETHAN M. BASCH
-
依托单位:
Cancer Care Quality Research Training Program
-
批准号:8473574
-
项目类别:
-
资助金额:$45.7万
-
财政年份:2008
-
负责人:ETHAN M. BASCH
-
依托单位:
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting
-
批准号:7385463
-
项目类别:
-
资助金额:$13.4万
-
财政年份:2008
-
负责人:ETHAN M. BASCH
-
依托单位:
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting
-
批准号:8042678
-
项目类别:
-
资助金额:$13.4万
-
财政年份:2008
-
负责人:ETHAN M. BASCH
-
依托单位:
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting
-
批准号:8234807
-
项目类别:
-
资助金额:$13.33万
-
财政年份:2008
-
负责人:ETHAN M. BASCH
-
依托单位:
Cancer Care Quality Research Training Program
-
批准号:8710025
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2008
-
负责人:ETHAN M. BASCH
-
依托单位:
Cancer Care Quality Research Training Program
-
批准号:9129603
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2008
-
负责人:ETHAN M. BASCH
-
依托单位:
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting
-
批准号:7596485
-
项目类别:
-
资助金额:$13.4万
-
财政年份:2008
-
负责人:ETHAN M. BASCH
-
依托单位:
R&D-OTHER R & D-A RES/EXPL DEV
-
批准号:7952669
-
项目类别:
-
资助金额:$104.98万
-
财政年份:2008
-
负责人:ETHAN M. BASCH
-
依托单位:
Cancer Care Quality Training Program
-
批准号:10221611
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2005
-
负责人:ETHAN M. BASCH
-
依托单位:
Cancer Care Quality Research Training Program
-
批准号:9348589
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2005
-
负责人:ETHAN M. BASCH
-
依托单位:
Cancer Care Quality Training Program
-
批准号:10459369
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2005
-
负责人:ETHAN M. BASCH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: